LOSE UP TO 3x MORE WEIGHT
THAN WITH A DIET ALONE*
- SO EASY! DIRECT DOSE,
NO WATER NEEDED!
- Take the sticks anywhere it suits you.
- Natural active ingredient & clinically proven.
- Delicious berry flavor.
XLS Medical Direct makes weight management easier than ever before thanks to its convenient stick format. It is an ideal tool for losing weight and keeping it off.
XLS Medical Direct has a unique triple action effect:
- Binds up to 28% of fat intake
- Reduces appetite and sweet cravings
- Improves gastrointestinal transit
- Cholesterol reduction
- Metabolic syndrome reduction
XLS Medical Direct is suitable for any adult who is overweight no matter their diet. It can help you to lose up to 3x more weight than with a diet alone.*
- Just put 1 stick, 3 times a day, directly into the mouth. No water needed.
- If you are eating, the stick should be taken after meals.
- Do not exceed 3 sticks a day.
- Take XLS Medical Direct for one month or more, depending on your weight loss targets.
- For beneficial actions of fibers on gastrointestinal transit, it is recommended to drink at least 2L of water a day
- XLS Medical Direct is made with , a patented fibre complex of natural and organic plant source that is clinically proven to bind dietary fats.
- XLS Medical Direct binds up to 28 % of dietary fats in the stomach by absorbing the fat molecules to form a fat-fibre complex. It works mechanically in your stomach and doesn’t interact with your body.
UNIQUE MODE OF ACTION :
- XLS Medical Direct is made with a natural active ingredient and has a well established safety profile.
- XLS Medical reduces fat absorption by up to 28% with no undesirable side effects
- XLS Medical reduces LDL-Cholesterol (bad cholesterol) by 10% within 14 days4
- XLS Medical reduces metabolic syndrome by 39% within 42 days4
- XLS Medical has a proven effect on the feeling of fullness: 80% of patients reported a moderate to high increase in fullness2
- XLS Medical helps you to lose up to 3X more weight than with a diet alone.*
- All these results are achieved with no undesirable side effects
1. In vivo Pilot Clinical Study, placebo-controlled, double-blind clinical study, conducted by CERN, (Centre d’Enseignement et de Recherche en Nutrition) in France, 2003.
2. In vivo, 2-armed, randomised, placebo-controlled, double-blind study, conducted in Germany, 2009.
3. Double-blind, randomized, placebo-controlled, crossover clinical investigation to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, Germany, 2012.
4. Linarès E. et al., The effect of NeOpuntia on Blood Lipid Parameters – Risk Factors for the Metabolic Syndrome (Syndrome X), Advances in Therapy, September/October 2007.